How does Flatiron reduce the burden of PMC/PMR studies for sponsors, sites, and patients?

In this video, Flatiron's Vice President of Research Oncology, shares how a pragmatic approach to postmarketing commitments and postmarketing requirements (PMCs/PMRs) can enable sponsors to reduce the burden of these studies for sites and patients.

Other videos from this series:

• What role does technology play in PMC/PMR studies, supported by Flatiron?

• What role do services play in PMC/PMR studies, supported by Flatiron?

• How do technology and operational services complement each other in PMC/PMR studies, supported by Flatiron?

• How are PMC/PMR studies different for sites, compared to traditional studies?

• How do sites support PMC/PMR studies today and how might that look differently, working with Flatiron?

• What are the challenges sponsors face today when pursuing a PMR/PMR study?

• Why is patient enrollment challenging for PMC/PMR studies?

• What does a pragmatic approach to PMR/PMRs, look like for sponsors?

• What's the consequence of failure in PMC/PMR studies?

• What's the value in leveraging prospective data vs. retrospective data in PMC/PMR studies?

• How does Flatiron help sponsors make decisions on what data to use in a PMC/PMR study?

Learn more about our clinical research solutions

Interested in seeing how Flatiron is bridging the gap between care and research?